1.1 Market Outlook
1.2 Key Findings
1.3 Business Trends
1.4 Regional Trends
1.5 Segmentation Snapshot
1.6 Competitive Insights
2.1 Research Objectives
2.2 Research Approach & Assumptions
2.3 Data Sourcing Methodology
2.4 Research Data
2.4.1 Primary Research
2.4.2 Secondary Research
2.4.2.1 Paid Data Sources
2.4.2.2 Public Data Sources
2.5 Market Size Estimation & Data Triangulation
2.6 Forecast Modeling
2.7 Limitations of the Study
3.1 Market Definition
3.2 Key Segmentations
3.3 Key Developments
3.4 Allied Industry Data
4.1 Industry Segmentation
4.2 Technology & Innovation Landscape
4.3 Oncology Diagnostics Value Chain Analysis
4.4 Macroeconomic Indicators
4.5 Recent Developments
4.6 Market Dynamics
4.6.1 Introduction
4.6.2 Growth Drivers
4.6.3 Market Opportunities
4.6.4 Market Restraints
4.6.5 Market Trends
4.7 Risk Analysis
4.8 Market Analysis
4.8.1 Porter’s Five Forces Analysis
4.8.2 PEST Analysis
4.8.2.1 Political
4.8.2.2 Economic
4.8.2.3 Social
4.8.2.4 Technological
5.1 Market Overview
5.2 Historical Analysis (2019–2023)
5.2.1 Market Size, Y-o-Y Growth & Market Forecast
6.1 Overview
6.2 Key Findings
6.3 Market Segmentation
6.3.1.1 Imaging Diagnostics
• By Value (USD Million), 2025–2035F
• Market Share, 2025–2035F
• Y-o-Y Growth, 2025–2035F
6.3.1.2 Molecular Diagnostics
6.3.1.3 Tissue Diagnostics / Histopathology
6.3.1.4 Biomarker Testing
6.3.1.5 Companion Diagnostics
6.3.2.1 Lung Cancer
6.3.2.2 Breast Cancer
6.3.2.3 Colorectal Cancer
6.3.2.4 Prostate Cancer
6.3.2.5 Cervical Cancer
6.3.2.6 Ovarian Cancer
6.3.2.7 Liver & Pancreatic Cancer
6.3.2.8 Others
6.3.3.1 Screening Tests
6.3.3.2 Early Detection Tests
6.3.3.3 Prognosis & Monitoring Tests
6.3.4.1 Hospitals & Clinics
6.3.4.2 Diagnostic Laboratories
6.3.4.3 Cancer Research Institutes
6.3.4.4 Ambulatory Care Centers
6.3.4.5 Academic & Research Organizations
7.1 Overview
7.2 Key Findings
7.3 Market Segmentation
7.4 Country Analysis
7.4.1 United States
7.4.2 Canada
8.1 Overview
8.2 Key Findings
8.3 Market Segmentation
8.4 Country Analysis
8.4.1 Germany
8.4.2 United Kingdom
8.4.3 France
8.4.4 Italy
8.4.5 Spain
8.4.6 Rest of Europe
9.1 Overview
9.2 Key Findings
9.3 Market Segmentation
9.4 Country Analysis
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 South Korea
9.4.5 Rest of Asia-Pacific
10.1 Overview
10.2 Key Findings
10.3 Market Segmentation
10.4 Country Analysis
10.4.1 Brazil
10.4.2 Mexico
10.4.3 Rest of Latin America
11.1 Overview
11.2 Key Findings
11.3 Market Segmentation
11.4 Country Analysis
11.4.1 Saudi Arabia
11.4.2 UAE
11.4.3 South Africa
11.4.4 Rest of MEA
12.1 Company Market Share Analysis
12.2 Key Stakeholders
12.3 Competitive Benchmarking
13.1 Roche Diagnostics
13.2 Abbott Laboratories
13.3 Thermo Fisher Scientific
13.4 Siemens Healthineers
13.5 GE Healthcare
13.6 Danaher Corporation
13.7 Bio-Rad Laboratories
13.8 Hologic, Inc.
13.9 Illumina, Inc.
13.10 Guardant Health
13.11 Exact Sciences Corporation
13.12 Myriad Genetics
13.13 Laboratory Corporation of America (Labcorp)
(Each profile includes: Company Overview, Financials, Product Portfolio, Market Share, Recent Developments, and Strategic Outlook)
Select License Type
Our Clients
We have been working with some Fortune 500+ clients
.png){kind=icon}
